That's the thinking behind a new institute set to be launched at The University of Nottingham that brings engineers, physicists, biologists and chemists together under one roof.
The Institute of Biophysics, Imaging and Optical Science (IBIOS) will develop novel imaging technologies using state-of-the-art equipment and use them to solve biological problems. The research could cover any biological system at any scale — from molecules to cells to whole tissue samples.
The institute will be home to a range of optical microscopy equipment and scanning probe systems, including a new scanning conductance ion microscope. Biological and chemical lab facilities will also be available. Software, hardware and silicon chip engineering facilities will allow researchers to build custom-made cameras, and develop systems designed to tackle specific biological problems.
One example of interdisciplinary research within IBIOS is the Research Councils UK (RCUK) Basic Technology Programme — Attogram. Under Attogram, IBIOS is developing new technologies for screening a range of diseases such as Chronic Obstructive Pulmonary Disorder (COPD), in collaboration with Exeter University. Screening COPD requires the testing of a large number of chemical markers simultaneously. The new system has unique chemistry, which attaches the biological markers to a sensor surface. Specially-designed optics can then interrogate large arrays of these bio-chemicals. Detection of the optical signals from the sensor surface has involved the development of novel camera technologies based on very large scale integration.
IBIOS was formed from two existing groups; the Cell Biophysics Group headed by Professor Paul O'Shea, which is part of the School of Biology; and the Applied Optics Group headed by Professor Mike Somekh in the School of Electrical and Electronic Engineering. The institute has also appointed two RCUK Academic Research Fellows in functional imaging, Dr Noah Russell and Dr Mark Pitter. These permanent positions are funded jointly by the University and the Research Councils. A masters research degree in biophotonics will be launched later this year.
“The philosophy of the institute combines state-of-the-art developments in optical imaging technology with curiosity-driven research into cellular biology,” said Prof O'Shea. “The key problems facing us in the investigation of the cell arise from the need to extract more quantitative information from biological systems. As the technology required to obtain this information is simply not available its development and application provides one of the major scientific and technological challenges for the future.”
“The institute provides an environment in which researchers from a range of disciplines can work in a close-knit community, with integrated facilities, with a shared research agenda. This is key to a successful interdisciplinary research programme.”
IBIOS has been funded by grants from EPSRC, RCUK, the European Union, the Wellcome Trust, BBSRC, GlaxoSmithKline and Roche.
The official launch of the Institute of Biophysics Imaging and Optical Science will take place on April 11 at the School of Biology. Speakers will discuss some of the rewards and pitfalls of working across the physical-biological science boundary. These include Professor Sir Colin Campbell, Vice-Chancellor of the University, Prof David Delpy FRS, Chief Executive of the Engineering and Physical Sciences Research Council, and Dr Jonathan Allis, Global Head of Imaging Technology at GE Healthcare Medical Diagnostics.
Emma Thorne | alfa
Decoding the regulation of cell survival - A major step towards preventing neurons from dying
04.10.2018 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden
New Cluster of Excellence “Centre for Tactile Internet with Human-in-the-Loop” (CeTI)
28.09.2018 | Technische Universität Dresden
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences